Dr. Jill Lacy discusses the development of immune therapies for pancreas cancer, the progress that is being made, and provides an update on CRS-207 and GVAX.
Dr. Jill Lacy discusses the development of immune therapies for pancreas cancer, the progress that is being made, and provides an update on CRS-207 and GVAX.